Azzur Group ("Azzur") Reaches Agreement to Sell Consulting Business for $56 Million to ELIQUENT Life Sciences

Azzur Group, a leading service provider to FDA-regulated pharmaceutical and biotech companies, today announced that it has reached an agreement to sell its consulting business to a strategic acquirer, ELIQUENT Life Sciences with the support of its investor GHO Capital, for $56 million. All Azzur Consulting employees and leadership are expected to transition to ELIQUENT and the business will continue to operate in the ordinary course with no intended operational changes as a result of this acquis

Mar 3, 2025 - 00:30
 0  5
Azzur Group ("Azzur") Reaches Agreement to Sell Consulting Business for $56 Million to ELIQUENT Life Sciences
Azzur Group, a leading service provider to FDA-regulated pharmaceutical and biotech companies, today announced that it has reached an agreement to sell its consulting business to a strategic acquirer, ELIQUENT Life Sciences with the support of its investor GHO Capital, for $56 million. All Azzur Consulting employees and leadership are expected to transition to ELIQUENT and the business will continue to operate in the ordinary course with no intended operational changes as a result of this acquis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow